Under bankruptcy, owners and financials
CVR: 41169303
DKK 1,077,483
Gross profit
Net result: DKK -396,379
2N Pharma Holding ApS (100%)
CVR · view owners
No current management
CVR · view management
Under bankruptcy
Founded 14 February 2020
CVR · view overview
1 employee
CVR · 2026
Director role ended: Preben Bruun-Nyzell
CVR · 27/04/2026
View the full event history
2N Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2020. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by 2N Pharma Holding ApS. The company has 1 employee (2026). In 2024, the company reported a gross profit of DKK 1,077,483 and a net result of DKK -396,379 compared with DKK -346,799 the year before. Equity in the 2024 report amounted to DKK 10,304,869.
Selskabets formål er at drive virksomhed med forskning, udvikling, kommercialisering, handel og fabrikation af lægemidler og dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | 1.1M | -396K | 26M | 10.3M | 3 | |
| 202301/01/2023 – 31/12/2023 | 543K | -347K | 21.8M | 10.7M | 3 | |
| 202201/01/2022 – 31/12/2022 | 2.2M | 270K | 19.7M | 11M | 3 | |
| 202101/01/2021 – 31/12/2021 | 1.5M | -318K | 16.8M | 8.9M | 5 | |
| 202014/02/2020 – 31/12/2020 | 336K | -188K | 10.8M | -148K | 1 |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Ved dekret af 27. april 2026 har Retten i Aalborg taget 2N Pharma ApS under konkursbehandling. Kurator: Advokat Peter Wedel Ranch Krarup, Amaliegade 10, 1256 København K. Sagsnr. SKS 31-189/2026.
Source: Statstidende, updated daily
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationYes. 2N Pharma ApS is registered in the Danish CVR register with the status under bankruptcy. The bankruptcy decree is published in Statstidende.
The CVR number of 2N Pharma ApS is 41169303.
2N Pharma ApS is owned by 2N Pharma Holding ApS.
In 2024, 2N Pharma ApS reported a gross profit of DKK 1,077,483.
2N Pharma ApS had 1 employee in 2026 according to the Danish CVR register.
2N Pharma ApS was founded on 14 February 2020.
On September 29, 2026, 2N Pharma ApS was placed under bankruptcy proceedings.
On April 29, 2026, a notice regarding 2N Pharma ApS was published in Statstidende: Konkursdekret (S27042026-64).
As of April 27, 2026, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of 2N Pharma ApS.
As of April 27, 2026, Preben Bruun-Nyzell has left the board of directors of 2N Pharma ApS.
As of April 27, 2026, Josephus Dirk Vestergaard Nieland has left the board of directors of 2N Pharma ApS.
As of April 27, 2026, Preben Bruun-Nyzell has stepped down as adm. dir. of 2N Pharma ApS.
As of April 27, 2026, Josephus Dirk Vestergaard Nieland has stepped down as director of 2N Pharma ApS.
2N Pharma ApS has published its annual report for 2024. Gross profit came to DKK 1,077,483, and the net result was DKK -396,379.
2N Pharma ApS has published its annual report for 2023. Gross profit came to DKK 543,215, and the net result was DKK -346,799.
As of September 4, 2023, John Kemp has left the board of directors of 2N Pharma ApS.
As of August 31, 2023, Alex Leech has left the board of directors of 2N Pharma ApS.
2N Pharma ApS has published its annual report for 2022. Gross profit came to DKK 2,221,899, and the net result was DKK 270,099.
2N Pharma ApS has published its annual report for 2021. Gross profit came to DKK 1,538,094, and the net result was DKK -318,464.
As of July 6, 2021, 2N Pharma Holding ApS is registered as an owner of 2N Pharma ApS with an ownership share of 100%.
2N Pharma ApS has published its interim report for the period February 14, 2020 to December 31, 2020.
As of June 28, 2021, Preben Bruun-Nyzell has joined the board of directors of 2N Pharma ApS.
As of June 28, 2021, Josephus Dirk Vestergaard Nieland has joined the board of directors of 2N Pharma ApS.
As of June 28, 2021, Alex Leech has joined the board of directors of 2N Pharma ApS.
As of June 28, 2021, John Kemp has joined the board of directors of 2N Pharma ApS.
As of June 28, 2021, Preben Bruun-Nyzell is registered as adm. dir. of 2N Pharma ApS.
As of June 27, 2021, Preben Bruun-Nyzell has stepped down as director of 2N Pharma ApS.
As of February 16, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2N Pharma ApS.
As of February 14, 2020, Preben Bruun-Nyzell is registered as director of 2N Pharma ApS.
As of February 14, 2020, Josephus Dirk Vestergaard Nieland is registered as director of 2N Pharma ApS.
2N Pharma ApS was founded on February 14, 2020.
Selskabets formål er besidde kapitalandele i datterselskaber og associerede selskaber samt at drive investeringsvirksomhed samt enhver i forbindelse hermed beslægtet virksomhed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 33864884
CVR 36036869
CVR 38322761
CVR 39606925
CVR 40237216
